Skip to main content

Advertisement

SpringerLink
Log in

Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene polymorphisms have been reported to influence the risk for acute rejection (AR) in transplant recipients. However, the results still remain controversial and ambiguous. The objective of the current study was to conduct a meta-analysis investigating the association between polymorphisms in the CTLA-4 gene and the risk of AR in transplant recipients. Electronic searches for all publications were conducted on associations between this variant and acute rejection in Medline and Embase databases through November 2011. Crude odds ratios (ORs) with 95 % confidence intervals (CIs) were calculated to estimate the strength of the association. Three polymorphisms (+49 adenine/guanine [+49A/G], −318 cytosine/thymine [−318C/T], and the +6230G/A polymorphism [CT60]) in 18 case–control studies from ten articles were analyzed. This meta-analysis included 2,081 cases of transplant recipients in which 813 cases developed AR and 1,268 cases did not develop AR. The results indicated that there was no statistically significant association between the risk of AR and the +49A/G polymorphism or the −318C/T polymorphism (+49A/G: OR = 0.876, 95 % CI = 0.650–1.180 for GG vs. AA; OR = 1.121, 95 % CI = 0.911–1.379 for AG + GG vs. AA; −318C/T: OR = 0.397, 95 % CI = 0.138–1.143 for TT vs. CC; OR = 0.987, 95 %CI = 0.553–1.760 for CT + TT vs. CC). However, individuals who carried CT60 A allele might have a decreased risk of AR (AA vs. GG OR = 0.535, 95 % CI = 0.340–0.841, A vs. G OR = 0.759, 95 % CI = 0.612–0.914) in liver transplant recipients among Europeans, but because only two studies were included, so the result should be caution. In further stratified analyses for the +49A/G and the −318C/T polymorphisms, no obvious significant associations were found in subgroups of renal transplant recipients and Europeans, a reduced incidence of acute rejection was observed in liver transplant recipients that are homogenous for +49G (OR = 0.638, 95 % CI = 0.427–0.954 for GG vs. AA/AG), while this has not been observed in renal transplant recipients. Overall this meta-analysis suggests that +49A/G and the −318C/T polymorphisms in CTLA-4 may be not associated with the risk of rejection after organ transplantation, but CTLA +49A/G and +6230G/A polymorphisms may be associated with acute rejection after liver transplantation, not after renal transplantation. In future, more studies should be included to evaluate the association between +6230G/A polymorphism and AR risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yu AS, Ahmed A, Keeffe EB (2002) Liver transplantation: involving patient selection criteria. Can J Gastroenterol 15(11):729–738

    Article  Google Scholar 

  2. Sayegh MH, Turka LA (1998) The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338(25):1813–1821

    Article  CAS  PubMed  Google Scholar 

  3. Marder B, Schroppel B, Murphy B (2003) Genetic variability and transplantation. Curr Opin Urol 13(2):81–89

    Article  PubMed  Google Scholar 

  4. Sun T, Zhou Y, Yang M et al (2008) Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68(17):7025–7034

    Article  CAS  PubMed  Google Scholar 

  5. Qi P, Ruan CP, Wang H et al (2010) CTLA-4 +49A > G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis 25(1):39–45

    Article  PubMed  Google Scholar 

  6. Ghaderi A, Yeganeh F, Kalantari T et al (2004) Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 86(1):1–7

    Article  CAS  PubMed  Google Scholar 

  7. Ligers A, Teleshova N, Masterman T et al (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2(3):145–152

    Article  CAS  PubMed  Google Scholar 

  8. Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511

    Article  CAS  PubMed  Google Scholar 

  9. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129

    Article  Google Scholar 

  10. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 22:719–748

    CAS  PubMed  Google Scholar 

  11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  12. Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291–1306

    Article  PubMed  Google Scholar 

  13. Azarpira N, Malekhosseini SA, Aghdaie MH et al (2010) CTLA4 CT60A/G polymorphism in liver transplant recipients. Exp Clin Transpl 8(3):210–213

    Google Scholar 

  14. Haimila K, Turpeinen H, Alakulppi NS et al (2009) Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation. Transplantation 87(3):393–396

    Article  CAS  PubMed  Google Scholar 

  15. Kusztal M, Koscielska-Kasprzak K, Drulis-Fajdasz D et al (2010) The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transpl Immunol 23(3):121–124

    Article  CAS  PubMed  Google Scholar 

  16. Krichen H, Sfar I, Jendoubi-Ayed S et al (2009) Genetic polymorphisms of immunoregulatory proteins in acute renal allograft rejection. Transpl Proc 41(8):3305–3307

    Article  CAS  Google Scholar 

  17. Krichen H, Sfar I, Hadj kacem H et al (2010) (AT) Repeat in the 3′ untranslated region of the CTLA-4 gene and susceptibility to acute allograft rejection in Tunisian renal transplantation. Transpl Proc 42(10):4314–4317

    Article  CAS  Google Scholar 

  18. de Reuver P, Pravica V, Hop W et al (2003) Recipient CTLA-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transpl 3(12):1587–1594

    Article  Google Scholar 

  19. Marder BA, Schroppel B, Lin M et al (2003) The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transpl 3(4):424–431

    Article  CAS  Google Scholar 

  20. Tapirdamaz O, Pravica V, Metselaar HJ et al (2006) Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut 55(6):863–868

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Muro M, Rojas G, Botella C et al (2008) CT60 A/G marker of the 3′-UTR of the CTLA4 gene and liver transplant. Transpl Immunol 18(3):246–249

    Article  CAS  PubMed  Google Scholar 

  22. Dmitrienko S, Hoar DI, Balshaw R et al (2005) Immune response gene polymorphisms in renal transplant recipients. Transplantation 80(12):1773–1782

    Article  PubMed  Google Scholar 

  23. Wisniewski A, Kusztal M, Magott-Procelewska M et al (2006) Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transpl Proc 38(1):56–58

    Article  CAS  Google Scholar 

  24. Gorgi Y, Sfar I, Abdallah TB et al (2006) CTLA-4 exon 1 (+49) and promoter (−318) gene polymorphisms in kidney transplantation. Transpl Proc 38(7):2303–2305

    Article  CAS  Google Scholar 

  25. Gendzekhadze K, Rivas-Vetencourt P, Montano RF et al (2006) Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-α −308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol 16(3–4):194–199

    Article  CAS  PubMed  Google Scholar 

  26. Kim HJ, Jeong KH, Lee SH et al (2010) Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients. Transpl Immunol 24(1):40–44

    Article  CAS  PubMed  Google Scholar 

  27. Slavcheva E, Albanis Ea, Jiao Q et al (2001) Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 72(5):935–940

    Article  CAS  PubMed  Google Scholar 

  28. Scheipers P, Reiser H (1998) Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor. Immunol Res 18(2):103

    Article  CAS  PubMed  Google Scholar 

  29. Bernard D, Hansen JD, Du Pasquier L et al (2007) Costimulatory receptors in jawed vertebrates: conserved CD28, odd CTLA-4 and multiple BTLAs. Dev Comp Immunol 31(3):255–271

    Article  CAS  PubMed  Google Scholar 

  30. Kouki T, Sawai Y, Gardine CA et al (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 165(11):6606–6611

    Article  CAS  PubMed  Google Scholar 

  31. Donner H, Rau H, Walfish PG et al (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves’ disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82(1):143–146

    CAS  PubMed  Google Scholar 

  32. Agarwal K, Jones DE, Daly AK et al (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32(4):538–541

    Article  CAS  PubMed  Google Scholar 

  33. Agarwal K, Czaja AJ, Jones DE et al (2000) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31(1):49–53

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partly supported by the Grants from scientific and technological project of Anhui province (Code: 08010302189). We thank all the people who give the help for this study.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University, 17 Lujiang Road, Hefei, Anhui Province, 230001, China

    Cheng-lin Zhu, Qiang Huang, Chen-hai Liu & Fang Xie

Authors
  1. Cheng-lin Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chen-hai Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fang Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, Cl., Huang, Q., Liu, Ch. et al. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Mol Biol Rep 39, 8701–8708 (2012). https://doi.org/10.1007/s11033-012-1727-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1727-4

Keywords

Search

Navigation